Crossing The Floor: Ex-PhRMA And BIO Exec Murphy Moves To Head Up AAM
John Murphy Named As New President And CEO Of US Generics And Biosimilars Association
Murphy has moved from the originator to the off-patent side of the industry • Source: Shutterstock 
